181 related articles for article (PubMed ID: 31691080)
41. Diclofenac and Its Acyl Glucuronide: Determination of In Vivo Exposure in Human Subjects and Characterization as Human Drug Transporter Substrates In Vitro.
Zhang Y; Han YH; Putluru SP; Matta MK; Kole P; Mandlekar S; Furlong MT; Liu T; Iyer RA; Marathe P; Yang Z; Lai Y; Rodrigues AD
Drug Metab Dispos; 2016 Mar; 44(3):320-8. PubMed ID: 26714763
[TBL] [Abstract][Full Text] [Related]
42. Changes in expression of renal Oat1, Oat3 and Mrp2 in cisplatin-induced acute renal failure after treatment of JBP485 in rats.
Liu T; Meng Q; Wang C; Liu Q; Guo X; Sun H; Peng J; Ma X; Kaku T; Liu K
Toxicol Appl Pharmacol; 2012 Nov; 264(3):423-30. PubMed ID: 22992436
[TBL] [Abstract][Full Text] [Related]
43. Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior.
Lena N; Imbert AM; Pignon T; Favre R; Meyer G; Cano JP; Carcassonne Y
Cancer Chemother Pharmacol; 1984; 12(2):120-4. PubMed ID: 6697425
[TBL] [Abstract][Full Text] [Related]
44. Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function.
Henjakovic M; Hagos Y; Krick W; Burckhardt G; Burckhardt BC
Am J Physiol Renal Physiol; 2015 Nov; 309(10):F843-51. PubMed ID: 26377792
[TBL] [Abstract][Full Text] [Related]
45. Oat1/3 restoration protects against renal damage after ischemic AKI.
Schneider R; Meusel M; Betz B; Held C; Möller-Ehrlich K; Büttner-Herold M; Wanner C; Gekle M; Sauvant C
Am J Physiol Renal Physiol; 2015 Feb; 308(3):F198-208. PubMed ID: 25391897
[TBL] [Abstract][Full Text] [Related]
46. Impaired renal organic anion transport 1 (SLC22A6) and its regulation following acute myocardial infarction and reperfusion injury in rats.
Sirijariyawat K; Ontawong A; Palee S; Thummasorn S; Maneechote C; Boonphang O; Chatsudthipong V; Chattipakorn N; Srimaroeng C
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2342-2355. PubMed ID: 31125610
[TBL] [Abstract][Full Text] [Related]
47. Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
Mutsaers HA; van den Heuvel LP; Ringens LH; Dankers AC; Russel FG; Wetzels JF; Hoenderop JG; Masereeuw R
PLoS One; 2011 Apr; 6(4):e18438. PubMed ID: 21483698
[TBL] [Abstract][Full Text] [Related]
48. Altered Renal Expression of Relevant Clinical Drug Transporters in Different Models of Acute Uremia in Rats. Role of Urea Levels.
Brandoni A; Torres AM
Cell Physiol Biochem; 2015; 36(3):907-16. PubMed ID: 26065488
[TBL] [Abstract][Full Text] [Related]
49. JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Peng J; Ma X; Kaku T; Liu K
Toxicol Appl Pharmacol; 2013 Sep; 271(2):285-95. PubMed ID: 23707770
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of transport mechanisms of methotrexate in human choriocarcinoma cell lines by LC-MS/MS.
Bai M; Shen Q; Wu Y; Ma Z; Wang Y; Chen M; Liu D; Zhou L
J Pharm Biomed Anal; 2024 Sep; 247():116268. PubMed ID: 38823222
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of
Parvez MM; Shin HJ; Jung JA; Shin JG
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
[No Abstract] [Full Text] [Related]
52. Differential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3.
Burckhardt BC; Henjakovic M; Hagos Y; Burckhardt G
J Pharmacol Exp Ther; 2017 Sep; 362(3):450-458. PubMed ID: 28630284
[TBL] [Abstract][Full Text] [Related]
53. Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein.
Ikemura K; Hiramatsu SI; Shinogi Y; Nakatani Y; Tawara I; Iwamoto T; Katayama N; Okuda M
Sci Rep; 2019 Dec; 9(1):20359. PubMed ID: 31889141
[TBL] [Abstract][Full Text] [Related]
54. CP-25 ameliorates methotrexate induced nephrotoxicity via improving renal apoptosis and methotrexate excretion.
Wei X; Wu Y; Tang H; Wang B; Wang Y; Sun W; Asenso J; Xiao F; Wang C
J Pharmacol Sci; 2021 May; 146(1):21-28. PubMed ID: 33858651
[TBL] [Abstract][Full Text] [Related]
55. Differential interactions of the β-lactam cloxacillin with human renal organic anion transporters (OATs).
Lalanne S; Le Vée M; Lemaitre F; Le Corre P; Verdier MC; Fardel O
Fundam Clin Pharmacol; 2020 Aug; 34(4):476-483. PubMed ID: 32100322
[TBL] [Abstract][Full Text] [Related]
56. Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers.
Liu L; Cui Y; Chung AY; Shitara Y; Sugiyama Y; Keppler D; Pang KS
J Pharmacol Exp Ther; 2006 Jul; 318(1):395-402. PubMed ID: 16627748
[TBL] [Abstract][Full Text] [Related]
57. Acyclovir Brain Disposition: Interactions with P-gp, Bcrp, Mrp2, and Oat3 at the Blood-Brain Barrier.
Shan Y; Cen Y; Zhang Y; Tan R; Zhao J; Nie Z; Zhang J; Yu S
Eur J Drug Metab Pharmacokinet; 2022 Mar; 47(2):279-289. PubMed ID: 35112329
[TBL] [Abstract][Full Text] [Related]
58. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.
Ye J; Liu Q; Wang C; Meng Q; Peng J; Sun H; Kaku T; Liu K
Eur J Pharm Sci; 2012 Sep; 47(2):341-6. PubMed ID: 22728397
[TBL] [Abstract][Full Text] [Related]
59. Chlorothiazide is a substrate for the human uptake transporters OAT1 and OAT3.
Juhász V; Beéry E; Nagy Z; Bui A; Molnár E; Zolnerciks JK; Magnan R; Jani M; Krajcsi P
J Pharm Sci; 2013 May; 102(5):1683-7. PubMed ID: 23457060
[TBL] [Abstract][Full Text] [Related]
60. Investigation of the differential transport mechanism of cinnabar and mercury containing compounds.
Wang Y; Zhou S; Ma H; Shi JS; Lu YF
Environ Toxicol Pharmacol; 2019 Feb; 66():83-90. PubMed ID: 30639899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
